Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 18801-18850 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT02498613
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
PHASE2Active, not recruiting
122 participants
Started: Aug 31, 2016 · Completed: Apr 10, 2026
26 conditions2 sponsors16 locations
NCT02934451
Dental Malocclusion and Craniofacial Development in OI
N/AActive, not recruiting
75 participants
Started: Aug 31, 2016 · Completed: Dec 31, 2026
1 condition8 sponsors3 locations
NCT02908061
A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia
PHASE3Active, not recruiting
178 participants
Started: Aug 31, 2016 · Completed: Aug 31, 2026
1 condition1 sponsor7 locations
NCT02914899
Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community
EARLY_PHASE1Active, not recruiting
99 participants
Started: Aug 31, 2016 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT02747589
Feasibility of Stimulating the Visual Cortex in Blind
NAActive, not recruiting
5 participants
Started: Aug 31, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02859038
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)
PHASE3Active, not recruiting
489 participants
Started: Aug 31, 2016 · Completed: Jun 30, 2027
3 conditions1 sponsor8 locations
NCT02763917
AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma
NAActive, not recruiting
198 participants
Started: Aug 31, 2016 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT03938571
Standard Duodenal Switch vs. Single Anastomosis Duodeno-Ileostomy Duodenal Switch
NAActive, not recruiting
56 participants
Started: Aug 31, 2016 · Completed: Jan 31, 2029
4 conditions1 sponsor0 locations
NCT05135234
Developing a Physiological Understanding of High Duration Activity
NAActive, not recruiting
60 participants
Started: Aug 31, 2016 · Completed: Dec 31, 2025
8 conditions2 sponsors1 location
NCT02720419
IRIS-Synergy Cohort in the IRIS-DES Registry
N/AActive, not recruiting
3,000 participants
Started: Aug 31, 2016 · Completed: Feb 28, 2027
1 condition2 sponsors28 locations
NCT02817802
BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV
N/AActive, not recruiting
2,066 participants
Started: Aug 31, 2016 · Completed: Oct 31, 2025
1 condition1 sponsor2 locations
NCT02864771
Scandinavian Multicenter Study to Advance Risk Stratification in Heart Disease- Ventricular Arrhythmias
N/AActive, not recruiting
504 participants
Started: Aug 31, 2016 · Completed: Dec 31, 2050
4 conditions3 sponsors1 location
NCT02618252
Ultrasound vs Veinviewer in Patients With Difficulty IV Access
NAActive, not recruiting
216 participants
Started: Aug 31, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03038984
Are Rates of Colectomies, Resections, Mortalities and Cancer Reduced by Home Monitoring of IBD Patients ?
NAActive, not recruiting
120 participants
Started: Aug 31, 2016 · Completed: Aug 31, 2026
1 condition1 sponsor0 locations
NCT03344809
Enhancing Diagnosis in Chronic B-cell Lymphoproliferative Disorders Using Next-Generation Sequencing
N/AActive, not recruiting
127 participants
Started: Aug 31, 2016 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT02777528
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1
NAActive, not recruiting
79 participants
Started: Aug 31, 2016 · Completed: Mar 31, 2028
2 conditions1 sponsor39 locations
NCT02877433
4 mm Implants in Fixed Cross-Arch Prostheses
NAActive, not recruiting
40 participants
Started: Aug 31, 2016 · Completed: May 31, 2025
1 condition1 sponsor2 locations
NCT02875548
A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study
PHASE1/PHASE2Active, not recruiting
58 participants
Started: Aug 30, 2016 · Completed: Nov 3, 2025
8 conditions1 sponsor34 locations
NCT02893397
Supervised Exercise in Improving Physical Fitness Before Surgery in Patients With Resectable Bone Cancer
NAActive, not recruiting
45 participants
Started: Aug 30, 2016 · Completed: Aug 30, 2026
1 condition2 sponsors2 locations
NCT03217305
Neurally Adjusted Ventilatory Assist (NAVA) vs Pressure Support Ventilation After Cardiac Surgery
NAActive, not recruiting
20 participants
Started: Aug 30, 2016 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT03254420
Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.
NAActive, not recruiting
74 participants
Started: Aug 30, 2016 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT02713269
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
PHASE2Active, not recruiting
60 participants
Started: Aug 29, 2016 · Completed: Oct 28, 2025
13 conditions2 sponsors1 location
NCT02812667
Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
PHASE1Active, not recruiting
18 participants
Started: Aug 29, 2016 · Completed: Oct 24, 2025
1 condition2 sponsors1 location
NCT03663543
Intravenous Estrogen in Kidney Transplant Study
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Aug 26, 2016 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT02825836
Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects
PHASE1/PHASE2Active, not recruiting
130 participants
Started: Aug 26, 2016 · Completed: Dec 1, 2025
5 conditions1 sponsor17 locations
NCT02616666
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
PHASE4Active, not recruiting
632 participants
Started: Aug 25, 2016 · Completed: Jul 31, 2026
1 condition3 sponsors132 locations
NCT02595892
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE2Active, not recruiting
70 participants
Started: Aug 25, 2016 · Completed: Aug 5, 2026
4 conditions1 sponsor17 locations
NCT03158818
Chronic Hepatitis B Virus Infection in Zambia
N/AActive, not recruiting
326 participants
Started: Aug 23, 2016 · Completed: Jun 30, 2026
6 conditions3 sponsors1 location
NCT02868268
Neuroblastoma Precision Trial
N/AActive, not recruiting
93 participants
Started: Aug 22, 2016 · Completed: Dec 31, 2025
1 condition6 sponsors11 locations
NCT02845505
Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion
N/AActive, not recruiting
500 participants
Started: Aug 22, 2016 · Completed: Jun 30, 2026
1 condition2 sponsors12 locations
NCT02417662
Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer
NAActive, not recruiting
340 participants
Started: Aug 19, 2016 · Completed: Aug 31, 2028
1 condition2 sponsors19 locations
NCT02826434
Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer
PHASE1Active, not recruiting
22 participants
Started: Aug 18, 2016 · Completed: Sep 30, 2027
1 condition3 sponsors5 locations
NCT02581930
Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma
PHASE2Active, not recruiting
18 participants
Started: Aug 17, 2016 · Completed: Mar 17, 2026
3 conditions1 sponsor13 locations
NCT02670525
Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome
NAActive, not recruiting
338 participants
Started: Aug 17, 2016 · Completed: Jan 31, 2028
2 conditions1 sponsor15 locations
NCT03345446
Circulating RNAs in Acute Congestive Heart Failure
N/AActive, not recruiting
200 participants
Started: Aug 17, 2016 · Completed: Dec 31, 2026
3 conditions5 sponsors3 locations
NCT02721732
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
PHASE2Active, not recruiting
157 participants
Started: Aug 15, 2016 · Completed: Dec 31, 2025
19 conditions2 sponsors1 location
NCT04055753
Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma
N/AActive, not recruiting
24 participants
Started: Aug 12, 2016 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT02700386
Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
PHASE2Active, not recruiting
108 participants
Started: Aug 11, 2016 · Completed: Aug 31, 2025
1 condition1 sponsor3 locations
NCT02621151
Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder
PHASE2Active, not recruiting
60 participants
Started: Aug 11, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors5 locations
NCT02697227
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
NAActive, not recruiting
85 participants
Started: Aug 5, 2016 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT02861417
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
PHASE2Active, not recruiting
204 participants
Started: Aug 5, 2016 · Completed: Aug 31, 2026
14 conditions2 sponsors1 location
NCT06935071
Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update
N/AActive, not recruiting
300 participants
Started: Aug 4, 2016 · Completed: Aug 4, 2026
4 conditions1 sponsor1 location
NCT02621398
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
PHASE1Active, not recruiting
23 participants
Started: Aug 4, 2016 · Completed: Dec 30, 2042
3 conditions4 sponsors3 locations
NCT02838420
A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
PHASE3Active, not recruiting
187 participants
Started: Aug 3, 2016 · Completed: Jun 30, 2026
1 condition1 sponsor21 locations
NCT03737799
StartRight: Getting the Right Classification and Treatment From Diagnosis in Adults With Diabetes
N/AActive, not recruiting
1,815 participants
Started: Aug 1, 2016 · Completed: Dec 31, 2024
1 condition4 sponsors1 location
NCT04147806
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer
PHASE2Active, not recruiting
30 participants
Started: Aug 1, 2016 · Completed: Jul 13, 2026
1 condition1 sponsor1 location
NCT05313672
Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control Study
N/AActive, not recruiting
20 participants
Started: Aug 1, 2016 · Completed: Aug 1, 2026
1 condition1 sponsor0 locations
NCT06713876
Long-term Outcomes of Patients Undergoing ECMO-assisted PCI
N/AActive, not recruiting
220 participants
Started: Aug 1, 2016 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT02840409
Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)
PHASE2Active, not recruiting
109 participants
Started: Aug 1, 2016 · Completed: Aug 31, 2026
1 condition2 sponsors21 locations
NCT02915445
EpCAM CAR-T for Treatment of Advanced Solid Tumors
PHASE1Active, not recruiting
30 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location